MSB 3.21% $1.13 mesoblast limited

Cell Therapy News/Articles, page-12401

  1. 646 Posts.
    lightbulb Created with Sketch. 319
    totality of evidence might not currently fit with their plan for all cause ards because we dont currently have proof in over 65s and all cause ards risk is 5 x higher in those aged 75 to 85 vs all ages combined.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.